Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607139 · ClinicalTrials.gov registry record
Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors
A clinical trial, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- 28
- Enrollment target
NCT00607139: Completed study, sponsored by Jaeb Center for Health Research.
NCT00607139 is a clinical trial that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607139 has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The primary objective of this study will be to compare the glucose level at which counter-regulatory hormone responses occur during hypoglycemia in young children with diabetes, with the glucose level counter regulatory hormone responses that occur in older children with diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-04 |
What the finished NCT00607139 record still lists
NCT00607139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00607139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00607139 about?
NCT00607139 is a clinical study titled "Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors". The primary objective of this study will be to compare the glucose level at which counter-regulatory hormone responses occur during hypoglycemia in young children with diabetes, with the glucose level counter regulatory hormone responses that occur in older children with diabetes.
What is the current status of trial NCT00607139?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-12. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00607139?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia